Facebook Tracking Image

National Comprehensive Cancer Network

Educational Events & Programs

NCCN Patient Advocacy Summit:
Delivering Value for Patients Across the Oncology Ecosystem

SUMMIT UPDATES > Click here for the press release.


On December 11, 2019, NCCN hosted a summit entitled, Delivering Value for Patients Across the Oncology Ecosystem in Washington, DC.  

The gap between the understanding of value-based care from a patient perspective as compared to physicians and the health system is one of the biggest barriers to patient-centered care. This summit highlighted the patient perspective related to delivering value-based and high-quality cancer care, implications associated with the term value, and the application of the value proposition within policymaking and clinical decision-making. The Summit also provided an opportunity to assess progress in the application of value across the health care ecosystem, utilization of tools, data collection efforts, and evaluation of continued challenges and next steps to promote patient-centered care.

An article will be published in Journal of the National Comprehensive Cancer Network―JNCCN.

Please check back often for additional updates regarding the summit. If you have any meeting content or agenda questions, please contact Terrell Johnson, MPA, Policy and Advocacy Fellow, U.S. and Global Development. For any media questions, please contact Rachel Darwin, Public Relations Manager.


Supported by Adaptive Biotechnologies; AmerisourceBergen; an educational donation provided by Amgen; Apobiologix; Astellas; AstraZeneca through its NCCN Corporate Council Membership; Celgene Corporation; Coherus BioSciences, Inc.; Curium; Eisai Inc.; EMD Serono; Ferring Pharmaceuticals; Foundation Medicine, Inc.; Genentech; HELSINN; Heron; Incyte Corporation; Janssen Oncology, Pharmaceutical Companies of Johnson & Johnson; Kite, a Gilead Company; an independent educational grant from Merck & Co., Inc.; Novartis Oncology; Regeneron Pharmaceuticals Inc; Sanofi; Servier; Sirtex; Taiho Oncology; Takeda; TESARO, A GSK Company; and Verastem Oncology. Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb; Dendreon Pharmaceuticals LLC. This activity was made possible by Pharmacyclics, an AbbVie Company; NCCN’s 2019 Patient Advocacy was funded in part by a sponsorship from Jazz Pharmaceuticals Inc.

As of September 10, 2019.

Access the Library of White Papers!

NCCN offers a broad library of white papers from previous summits that may be pertinent to your organization.

View Supporter Opportunities.

NCCN offers organizations various supporter opportunities.